Anticoagulant Therapy in Difficult Patients with Atrial Fibrillation: When the Risks of Embolism and Bleeding Are Comparable

This article affects  the problems of using NOAC in the most defenseless groups  of patients with atrial fibrillation: those  who have high bleeding and high thromboembolic risk and elderly. The focus is on comparison of effectiveness and safety of NOACs based  on randomized clinical trials (RCT) an...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: D. A. Napalkov, A. A. Sokolova, M. A. Gabitova, L. N. Uddin
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Stolichnaya Izdatelskaya Kompaniya 2018-11-01
Seri Bilgileri:Racionalʹnaâ Farmakoterapiâ v Kardiologii
Konular:
atrial fibrillation
difficult patients
elderly
rivaroxaban
warfarin
Online Erişim:https://www.rpcardio.com/jour/article/view/1769
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller